Date of event
Continuing Education Credits
AASLD COVID-19 Clinical Oversight Subcommittee
- Anna S. Lok, MD, FAASLD
University of Michigan
- Alina M. Allen, MD
Mayo Clinic Rochester
Moderator / Presenter
- Norah Terrault, MD, MPH, FAASLD
Keck Medical Center of USC
- Michael W. Fried, MD, FAASLD
University of North Carolina at Chapel Hill
- Averell H. Sherker, MD, FAASLD
- Andrea E. Reid, MD, MPH
Harvard Medical School
The webinar is targeted to a broad range of clinical investigators in hepatology and is structured to discuss the current status of clinical research in all domains of hepatology and the need for innovative strategies moving forward.
This webinar will:
- Discuss the current status of clinical research in several domains of hepatology
- Present hurdles in reentry in clinical research
- Discuss potential innovative strategies to sustain academic development and discovery through clinical research in the post pandemic era
- Address current and future challenges in clinical research among Early-Mid Career Investigators
Attendees can submit their COVID-19 questions in advance via this survey. Our experts will select a few questions to discuss during the webinar. Questions must be received by Tuesday, August 4, 11:59 am ET. Once the deadline passes, you can submit your questions directly to the speakers during the live webinar, time permitting.
Anna S. Lok, MD, FAASLD
Dr. Lok graduated from the University of Hong Kong Medical School. She completed her hepatology training in London under Dame Sheila Sherlock. She joined the University of Michigan in 1995 as Director of the Hepatology Program. She became Associate Chair for Clinical Research in the Department of Internal Medicine in 2008 and Assistant Dean for Clinical Research in 2016.
Dr. Lok’s research focuses on natural history and treatment of hepatitis B and C. She has published more than 550 papers on viral hepatitis and liver diseases including the American Association for the Study of Liver Diseases (AASLD) guidelines on Hepatitis B. She also participated in the development of the first World Health Organization guidelines on hepatitis B and C. Dr. Lok has made important contributions to the understanding of factors influencing the progression of hepatitis B and C, and the development of new treatments of these diseases.
Dr. Lok received many awards throughout her career including the Distinguished Scientist Award from the Hepatitis B Foundation in 2008, the Distinguished Service Award from the AASLD in 2011, the William Beaumont Prize in Gastroenterology from the American Gastroenterological Association in 2016, a Gold Medal Award from the Canadian Association for the Study of the Liver and an Hon DSc from the University of Hong Kong in 2017, an International Recognition Award from the European Association for the Study of the Liver in 2018, and a Distinguished University Professorship from the University of Michigan in 2019.
Dr. Lok served as Associate Editor of HEPATOLOGY in 2002-6, co-Editor of Journal of Viral Hepatitis in 2007-9, Senior Associate Editor of GASTROENTEROLOGY in 2011-2012, and President of AASLD in 2017.
Alina M. Allen, MD
Dr. Alina M. Allen is an Assistant Professor of Medicine and the Director of the NAFLD Clinic in the Division of Gastroenterology and Hepatology at Mayo Clinic, where she completed her training in Gastroenterology/Hepatology and Transplant Hepatology. She is an NIH-funded investigator in the field of nonalcoholic fatty liver disease (NAFLD) with clinical expertise in liver diseases before and after liver transplantation. Her research interests include the development of noninvasive biomarkers for the diagnosis of nonalcoholic steatohepatitis (NASH), pathways to improve the identification and management of patients with NAFLD and liver diseases in women. Her research program includes biorepositories/biomarker databases, longitudinal population-based studies of natural history and clinical trials. She is actively involved in national societies as a member of the NAFLD Special Interest Group within the American Association for the Study for Liver Diseases and as a GRADE methodologist of the Clinical Practice Guideline Committee of the American Gastroenterology Association.
Norah Terrault, MD, MPH, FAASLD
Dr. Norah Terrault is Professor of Medicine and Chief of Gastroenterology and Liver Diseases at the Keck School of Medicine at University of Southern California. She received her MD from the University of Alberta and completed fellowships in Internal Medicine and Gastroenterology at the University of Toronto and a Masters in Public Health at the University of California at Berkeley. Dr. Terrault has focused her clinical and research activities on viral hepatitis and non-alcoholic fatty liver disease, especially in special populations including those with cirrhosis and those with transplants.
In addition to multiple clinical trials related to preventing and treating chronic hepatitis viral hepatitis and fatty liver, Dr. Terrault has been PI on multiple NIH-funded studies, including the current NIH-supported HBV clinical research network (HBRN) and nonalcoholic steatohepatitis clinical research network (NASH CRN). She has authored 330 peer-reviewed manuscripts, editorials, invited reviews as well as US national guidelines for treatment of chronic hepatitis B and C.
She is past associate editor for HEPATOLOGY and deputy editor for Liver Transplantation and co-edited Zakim and Boyer’s textbook in hepatology. She is the founder of ECHO-Plus, a multifaceted program to train and support primary care physicians in California to care for patients with hepatitis. She has a long history of mentoring fellows and junior faculty in clinical research and is passionate about creating research support and opportunities for the next generation of GI/Hepatology investigators. Dr. Terrault was recently elected as Councilor to the AASLD governing board and will serve as president in 2023.